Cyclodextrins as templates for the presentation of protease inhibitors

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L (1996)
FEBS LETTERS 391(3): 297-301.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Schaschke, NorbertUniBi; Musiol, HJ; AssfalgMachleidt, I; Machleidt, W; RudolphBohner, S; Moroder, L
Erscheinungsjahr
1996
Zeitschriftentitel
FEBS LETTERS
Band
391
Ausgabe
3
Seite(n)
297-301
ISSN
0014-5793
Page URI
https://pub.uni-bielefeld.de/record/2403889

Zitieren

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 1996;391(3):297-301.
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., & Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), 297-301. https://doi.org/10.1016/0014-5793(96)00752-1
Schaschke, Norbert, Musiol, HJ, AssfalgMachleidt, I, Machleidt, W, RudolphBohner, S, and Moroder, L. 1996. “Cyclodextrins as templates for the presentation of protease inhibitors”. FEBS LETTERS 391 (3): 297-301.
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., and Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS 391, 297-301.
Schaschke, N., et al., 1996. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), p 297-301.
N. Schaschke, et al., “Cyclodextrins as templates for the presentation of protease inhibitors”, FEBS LETTERS, vol. 391, 1996, pp. 297-301.
Schaschke, N., Musiol, H.J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., Moroder, L.: Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 391, 297-301 (1996).
Schaschke, Norbert, Musiol, HJ, AssfalgMachleidt, I, Machleidt, W, RudolphBohner, S, and Moroder, L. “Cyclodextrins as templates for the presentation of protease inhibitors”. FEBS LETTERS 391.3 (1996): 297-301.

8 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Carbohydrates in peptide and protein design.
Jensen KJ, Brask J., Biopolymers 80(6), 2005
PMID: 15929028
Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, Deluca D, Pfeiler D, Schaschke N, Moroder L, Machleidt W., Biol Chem 384(3), 2003
PMID: 12715890
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem Biol 8(4), 2001
PMID: 11325588
Synthesis of bivalent inhibitors of eucaryotic proteasomes.
Loidl G, Musiol HJ, Groll M, Huber R, Moroder L., J Pept Sci 6(1), 2000
PMID: 10674718
Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L., Bioorg Med Chem Lett 10(7), 2000
PMID: 10762052
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G, Groll M, Musiol HJ, Ditzel L, Huber R, Moroder L., Chem Biol 6(4), 1999
PMID: 10099130
Bivalency as a principle for proteasome inhibition.
Loidl G, Groll M, Musiol HJ, Huber R, Moroder L., Proc Natl Acad Sci U S A 96(10), 1999
PMID: 10318898

34 References

Daten bereitgestellt von Europe PubMed Central.


Wenz, Angew. Chem. 106(), 1994
Cyclodextrin derivatives in pharmaceutics.
Albers E, Muller BW., Crit Rev Ther Drug Carrier Syst 12(4), 1995
PMID: 9501966

Parrot-Lopez, Tetrahedron Lett. 31(), 1990

Djedaini-Pilard, Tetrahedron Lett. 34(), 1993

Hristova-Kazmierski, Bioorg. Med. Chem. Lett. 3(), 1993

Corradini, Chem. Eur. J. 2(), 1996

Takahashi, Supramol. Chem. 2(), 1993

Djedaini-Pilard, J. Chem. Soc. Perkin Trans. 2(), 1995
A self-included cyclomaltoheptaose derivative studied by NMR spectroscopy and molecular modelling.
Berthault P, Duchesne D, Desvaux H, Gilquin B., Carbohydr. Res. 276(2), 1995
PMID: 8542602

Selkti, Supramol. Chem. 5(), 1995
Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
Sasaki T, Kishi M, Saito M, Tanaka T, Higuchi N, Kominami E, Katunuma N, Murachi T., J. Enzym. Inhib. 3(3), 1990
PMID: 2079636

Fehrentz, Synthesis (), 1983

Ito, Chem. Pharm. Bull. 23(), 1975

Ito, Chem. Pharm. Bull. 23(), 1975

Graybill, Int. J. Peptide Protein Res. 44(), 1994

Melton, Carbohydr. Res. 18(), 1971

Vaultier, Tetrahedron Lett. 24(), 1983

Coste, Tetrahedron Lett. 31(), 1990

Bax, J. Magn. Reson. 65(), 1985

Braunschweiler, J. Magn. Reson. 53(), 1983

States, J. Magn. Reson. 48(), 1982

Jeener, J. Chem. Phys. 71(), 1979

Gueron, Prog. NMR Spectrosc. 23(), 1991

Bax, J. Magn. Reson. 63(), 1985
Temporary inhibition of papain by hairpin loop mutants of chicken cystatin. Distorted binding of the loops results in cleavage of the Gly(9)-Ala10 bond.
Machleidt W, Nagler DK, Assfalg-Machleidt I, Stubbs MT, Fritz H, Auerswald EA., FEBS Lett. 361(2-3), 1995
PMID: 7698320

AUTHOR UNKNOWN, 0

Morrison, Trends Biochem. Sci. 7(), 1982

Parrot-Lopez, Tetrahedron Asym. 1(), 1990

Saka, Bull. Chem. Soc. Jap. 66(), 1993

AUTHOR UNKNOWN, 0

Cramer, J. Am. Chem. Soc. 89(), 1967
The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N., EMBO J. 10(9), 1991
PMID: 1868826
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 8764993
PubMed | Europe PMC

Suchen in

Google Scholar